In Eli Lilly and Company v Grace Beaumont et. al. (Claim Number FA1504001615093), represented by Stephanie A. Gumm of Faegre Baker Daniels, LLP, Eli Lilly succeeded in consolidating 392 domain names registered across several registrars, and using multiple aliases, in a single UDRP proceeding. The domains were all ordered to be transferred to Eli Lilly. In arguing for consolidation of Respondents, Complainant relied on testimony from Maccabim.com’s CEO Jonathan Matkowsky that the disputed domain names are under the control of a criminal network that uses false contact information to register domains, including compromised identities of innocent third persons. Maccabim’s testimony was supported by email correspondence received by the NATIONAL ARBITRATION FORUM from various named registrants of the disputed domain names who denied having registered the domain names.
DISCLAIMER: THE OPINIONS AND CHARACTERIZATION OF THE ELI LILLY DECISION REPRESENTS SOLELY THE VIEWS OF MACCABIM.COM LTD., AND SHOULD NOT BE CONSTRUED TO REFLECT THE VIEWS OR OPINIONS OF ELI LILLY OR ITS COUNSEL IN ANY WAY.